Report cover image

Fill-finish Pharmaceutical Contract Manufacturing Market – By Product (Vials [Glass, Plastic], Prefilled Syringe, Cartridges), Molecule (Large & Small Molecules), End-use (Biopharmaceutical & Pharmaceutical Companies), Global Forecast (2024 – 2032)

Published Apr 29, 2024
Length 182 Pages
SKU # GMI19004558

Description

Table of Contents

182 Pages
Report Content Chapter 1 Methodology & Scope 1.1 Market scope & definitions 1.2 Research design 1.2.1 Research approach 1.2.2 Data collection methods 1.3 Base estimates & calculations 1.3.1 Base year calculation 1.3.2 Key trends for market estimation 1.4 Forecast model 1.5 Primary research and validation 1.5.1 Primary sources 1.5.2 Data mining sources Chapter 2 Executive Summary 2.1 Industry 360 degree synopsis Chapter 3 Industry Insights 3.1 Industry ecosystem analysis 3.2 Industry impact forces 3.2.1 Growth drivers 3.2.1.1 Growing trend of pharmaceutical outsourcing 3.2.1.2 Rising technological advancements in fill-finish manufacturing processes 3.2.1.3 Increasing complexity of drug formulations 3.2.2 Industry pitfalls & challenges 3.2.2.1 Stringent regulatory issues 3.2.2.2 Competition from in-house manufacturing 3.3 Growth potential analysis 3.4 Regulatory landscape 3.5 Porter's analysis 3.6 PESTEL analysis Chapter 4 Competitive Landscape, 2023 4.1 Introduction 4.2 Company matrix analysis 4.3 Competitive analysis of major market players 4.4 Competitive positioning matrix 4.5 Strategy dashboard Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn) 5.1 Key trends 5.2 Vials 5.2.1 Glass vials 5.2.2 Plastic vials 5.3 Prefilled syringes (PFS) 5.3.1 Glass PFS 5.3.2 Plastic PFS 5.4 Cartridges 5.5 Other products Chapter 6 Market Estimates and Forecast, By Molecule, 2021 - 2032 ($ Mn) 6.1 Key trends 6.2 Large molecules 6.3 Small molecules Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn) 7.1 Key trends 7.2 Biopharmaceutical companies 7.3 Pharmaceutical companies Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn) 8.1 Key trends 8.2 North America 8.2.1 U.S. 8.2.2 Canada 8.3 Europe 8.3.1 Germany 8.3.2 UK 8.3.3 France 8.3.4 Spain 8.3.5 Italy 8.3.6 Netherlands 8.3.7 Rest of Europe 8.4 Asia Pacific 8.4.1 China 8.4.2 Japan 8.4.3 India 8.4.4 Australia 8.4.5 South Korea 8.4.6 Rest of Asia Pacific 8.5 Latin America 8.5.1 Brazil 8.5.2 Mexico 8.5.3 Rest of Latin America 8.6 Middle East and Africa 8.6.1 South Africa 8.6.2 Saudi Arabia 8.6.3 UAE 8.6.4 Rest of Middle East and Africa Chapter 9 Company Profiles 9.1 Boehringer Ingelheim International GmbH 9.2 Catalent Inc. 9.3 Eurofins Scientific 9.4 Fresenius Kabi Contract Manufacturing 9.5 MabPlex International Co. Ltd. 9.6 Novartis AG 9.7 Recipharm AB 9.8 Societal CDMO 9.9 Simtra BioPharma Solutions (Baxter International Inc.) 9.10 Symbiosis Pharmaceutical Services
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.